Skip to main navigation Skip to search Skip to main content

Novel gene therapeutic strategies for the induction of tolerance in cornea transplantation

  • Charité – Universitätsmedizin Berlin

Research output: Contribution to a Journal (Peer & Non Peer) › Review article › peer-review

10 Citations (Scopus)

Abstract

With more than 100,000 procedures each year, corneal transplantation (keratoplasty) is the most frequent transplantation procedure in humans. Technical advances in microsurgery have moved forward to transplant isolated layers of the cornea; however, immune-mediated allograft rejection is still a key problem and continued therapeutic efforts are required to improve the prognosis of keratoplasty. New treatment protocols need to be introduced to prevent the rejection of allogeneic grafts. The genetic modification of the graft or cells prior to transplantation is an attractive approach to protect the graft from allogeneic rejection. The transplant setting offers the unique advantage for gene therapy to modify allografts ex vivo prior to transplantation. In this review, novel therapeutic strategies using recombinant viruses as gene-transfer vehicles and, more recently, the use of gene-modified dendritic cells or regulatory T cells to protect the graft from immune-mediated rejection will be discussed.

Original languageEnglish
Pages (from-to)749-764
Number of pages16
JournalExpert Review of Clinical Immunology
Volume5
Issue number6
DOIs
Publication statusPublished - Nov 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adenovirus
  • Cornea
  • Gene therapy
  • Immunomodulation
  • Retrovirus
  • Transplantation

Fingerprint

Dive into the research topics of 'Novel gene therapeutic strategies for the induction of tolerance in cornea transplantation'. Together they form a unique fingerprint.

Cite this